Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 684,042 | 636,504 | 387,196 | 82,076 | 45,194 |
| Marketable Securities | N/A | N/A | N/A | 75,822 | 0 |
| Receivables | 186,371 | 124,805 | 75,480 | 34,374 | 22,081 |
| Inventories | 30,037 | 28,669 | 26,525 | 3,909 | 5,046 |
| Income taxes - deferred | 48,440 | 33,613 | 35,813 | N/A | N/A |
| Other current assets | 54,155 | 33,843 | 19,113 | 1,260 | 279 |
| TOTAL | $1,015,845 | $864,617 | $551,572 | $199,131 | $74,458 |
| Non-Current Assets | |||||
| PPE Net | 58,363 | 14,246 | 7,281 | 1,557 | 690 |
| Intangibles | 2,140,148 | 1,262,852 | 1,312,552 | 52,798 | 60,246 |
| Other Non-Current Assets | 124,599 | 96,506 | 95,088 | 87 | 335 |
| TOTAL | $2,323,110 | $1,373,604 | $1,414,921 | $54,442 | $61,271 |
| Total Assets | $3,338,955 | $2,238,221 | $1,966,493 | $253,573 | $135,729 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 9,428 | 5,572 | 29,688 | 0 | 23,414 |
| Accounts payable and accrued liabilities | 25,126 | 21,005 | 15,887 | 5,129 | 3,049 |
| Accrued Expenses | 164,091 | 119,718 | 104,666 | 34,783 | 23,572 |
| Other current liabilities | N/A | 50,000 | 0 | 11,820 | 8,628 |
| TOTAL | $216,801 | $204,028 | $191,538 | $52,870 | $59,936 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,333,000 | 544,404 | 427,073 | 0 | 24,629 |
| Deferred Revenues | 1,138 | 1,138 | 1,138 | 1,138 | 1,273 |
| Other Non-Current Liabilities | 39,454 | 20,040 | 41,421 | 0 | 11,478 |
| TOTAL | $1,750,946 | $738,659 | $653,663 | $7,915 | $45,242 |
| Total Liabilities | $1,967,747 | $942,687 | $845,201 | $60,785 | $105,178 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,657 | 58,068 | 58,038 | 56,244 | 40,295 |
| Common Shares | 61 | 61 | 61 | 4 | 4 |
| Retained earnings | 35,175 | 19,003 | -60,825 | -349,882 | -474,866 |
| Other shareholders' equity | -122,033 | 56,153 | 31,046 | -31 | 0 |
| TOTAL | $1,371,208 | $1,295,534 | $1,121,292 | $192,788 | $30,551 |
| Total Liabilities And Equity | $3,338,955 | $2,238,221 | $1,966,493 | $253,573 | $135,729 |